These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7595137)

  • 1. Effect of oral calcium supplementation on intracellular calcium and plasma renin in men.
    Lijnen P; Petrov V
    J Endocrinol; 1995 Sep; 146(3):421-9. PubMed ID: 7595137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of intracellular calcium and plasma renin by dietary calcium in men.
    Petrov V; Lijnen P
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1217-24. PubMed ID: 10619585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary calcium, blood pressure and cell membrane cation transport systems in males.
    Lijnen P; Petrov V
    J Hypertens; 1995 Aug; 13(8):875-82. PubMed ID: 8557965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and cationic transport systems during combined calcium channel blocker and calcium administration in males.
    Lijnen P; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):287-94. PubMed ID: 8803961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes.
    Herrera JA; Arévalo-Herrera M; Shahabuddin AK; Ersheng G; Herrera S; Garcia RG; López-Jaramillo P
    Am J Hypertens; 2006 Apr; 19(4):381-7. PubMed ID: 16580574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.
    Lind L; Wengle B; Wide L; Ljunghall S
    Am J Hypertens; 1989 Jan; 2(1):20-5. PubMed ID: 2643969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane cation transport systems during aldosterone antagonism.
    Lijnen P; Petrov V
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):462-8. PubMed ID: 8847860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.
    Sanjuliani AF; de Abreu Fagundes VG; Francischetti EA
    Int J Cardiol; 1996 Oct; 56(2):177-83. PubMed ID: 8894790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium metabolism in essential hypertension: relationship to altered renin system activity.
    Resnick LM; Nicholson JP; Laragh JH
    Fed Proc; 1986 Nov; 45(12):2739-45. PubMed ID: 3533639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
    Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nicardipine on sodium and calcium metabolism in hypertensive patients: a chronic study.
    Soro S; Cocca A; Pasanisi F; Tommaselli A; de Simone G; Costantino G; Ferrara LA
    J Clin Pharmacol; 1990 Feb; 30(2):133-7. PubMed ID: 2179277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed calcium metabolism in offspring of hypertensive parents.
    Yamakawa H; Suzuki H; Nakamura M; Ohno Y; Saruta T
    Hypertension; 1992 Jun; 19(6 Pt 1):528-34. PubMed ID: 1592447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
    Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
    Muller ME; Forni Ogna V; Maillard M; Stoudmann C; Zweiacker C; Anex C; Wuerzner G; Burnier M; Bonny O
    Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension.
    Burgess ED; Hawkins RG; Watanabe M
    Am J Hypertens; 1990 Dec; 3(12 Pt 1):903-5. PubMed ID: 2081010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients.
    Sánchez M; de la Sierra A; Coca A; Poch E; Giner V; Urbano-Márquez A
    Hypertension; 1997 Jan; 29(1 Pt 2):531-6. PubMed ID: 9039155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind randomized, crossover trial of calcium supplementation in essential hypertension.
    Zoccali C; Mallamaci F; Delfino D; Ciccarelli M; Parlongo S; Iellamo D; Moscato D; Maggiore Q
    J Hypertens; 1988 Jun; 6(6):451-5. PubMed ID: 3045202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in blood pressure during altered sodium intake is not associated with calciotropic hormone level.
    Ozono R; Oshima T; Matsuura H; Ishibashi K; Watanabe M; Yoshimura M; Kajiyama G; Kambe M
    Clin Sci (Lond); 1997 Aug; 93(2):153-7. PubMed ID: 9301430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.